Trials / Completed
CompletedNCT05020756
Study in Children Who Have Switched to Isosource Junior Mix Formula
A Retrospective Study in Children Who Have Switched to Isosource Junior Mix Formula (RICIMIX Study)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 12 Months – 14 Years
- Healthy volunteers
- Not accepted
Summary
A Retrospective study In Children who have switched to Isosource Junior Mix formula (RICIMIX study) will review paediatric children \> 12 months of age who require Isosource Junior Mix as an enteral tube feeding formula and have consumed the formula for at least 1 month. The purpose of this study is to understand If there has been an improvement in outcomes/ experiences * The current usage of ISJMIX formula in children who require blended diets * Improved feeding intolerances * Improved patient outcomes/ experiences
Detailed description
Retrospective data will be collected using questionnaire by the dietitians at the nutrition and dietetic department. All completed questionnaires will be sent back to Nestle Health Science/ CRO company. The primary objectives: The following measures will be collected retrospectively after 1 month use of ISJMIX * Feeding tolerance \[no change, tolerance improved, tolerance worsened\]: gastric residuals, gagging/retching, vomiting, abdominal distention/ gas, stool consistency issues (too hard, too loose) * Volume of formula consumed in a day The secondary objective is to collect restropective data on: * Any improved patient outcomes noted * Calculate the potential cost savings made when using ISJMIX to help manage the feeding intolerances * Calculate the potential costs benefit of using ISJMIX over other standard formulas
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Isosource Junior Mix | Single arm study, collecting data on those who have been on Isosourcr Junior mix tube feed formula for 30 days |
Timeline
- Start date
- 2021-03-26
- Primary completion
- 2021-03-26
- Completion
- 2021-08-02
- First posted
- 2021-08-25
- Last updated
- 2024-11-06
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05020756. Inclusion in this directory is not an endorsement.